|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM067057640 |
| 003 |
DE-627 |
| 005 |
20231221235118.0 |
| 007 |
tu |
| 008 |
231221s1984 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0224.xml
|
| 035 |
|
|
|a (DE-627)NLM067057640
|
| 035 |
|
|
|a (NLM)6728863
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Dolecek, R
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Growth hormone plasma levels in children treated for 6 months with ketotifen
|
| 264 |
|
1 |
|c 1984
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 29.06.1984
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Twelve children with pollinosis or bronchial asthma were treated continuously, without interruption, for 6 months with ketotifen (2 mg per day). In the first group of 6 children, growth hormone and blood glucose levels were measured during insulin tolerance tests (-15, 0, 30 and 60 min) and growth hormone levels during the late evening when the children were asleep, before and after 3 and 6 months of treatment. In the second group of 6 children, growth hormone and blood glucose levels were measured during protracted insulin tolerance tests (-15, 0, 15, 30, 45, 60, 75, 90, 105 and 120 min) at the same periods. The results showed that the growth hormone increases and blood glucose decreases were generally the same before and during ketotifen treatment. Growth rate and weight gain in the treated groups were similar to those in control groups of untreated children and were not lower than the average values for Czech children of the same age. Measurements of thyroid stimulating hormone and prolactin levels showed that these also wer not altered during long-term ketotifen administration
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Blood Glucose
|2 NLM
|
| 650 |
|
7 |
|a Prolactin
|2 NLM
|
| 650 |
|
7 |
|a 9002-62-4
|2 NLM
|
| 650 |
|
7 |
|a Thyrotropin
|2 NLM
|
| 650 |
|
7 |
|a 9002-71-5
|2 NLM
|
| 650 |
|
7 |
|a Growth Hormone
|2 NLM
|
| 650 |
|
7 |
|a 9002-72-6
|2 NLM
|
| 650 |
|
7 |
|a Ketotifen
|2 NLM
|
| 650 |
|
7 |
|a X49220T18G
|2 NLM
|
| 700 |
1 |
|
|a Janstová, V
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Halatová, A
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
|d 1995
|g 3(1984), 9 vom: 11., Seite 588-91
|w (DE-627)NLM023961570
|
| 773 |
1 |
8 |
|g volume:3
|g year:1984
|g number:9
|g day:11
|g pages:588-91
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 3
|j 1984
|e 9
|b 11
|h 588-91
|